Inhaled epoprostenol vs inhaled nitric oxide for refractory hypoxemia in critically ill patients

Journal of Critical Care

Volumn 28, Issue 5, 2013, Pages 844-848

  Torbic, Heather ^a   Szumita, Paul M ^a   Anger, Kevin E ^a   Nuccio, Paul ^a   LaGambina, Susan ^a   Weinhouse, Gerald ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

ARDS; Epoprostenol; Hypoxemia; Nitric oxide; Pulmonary vasodilator

Indexed keywords

NITRIC OXIDE; PROSTACYCLIN;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTERIAL OXYGEN FRACTION OF INSPIRED OXYGEN RATIO; ARTICLE; ARTIFICIAL VENTILATION; BLEEDING; COHORT ANALYSIS; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DRUG COST; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE CONCENTRATE; FEMALE; HEART FAILURE; HEART RIGHT VENTRICLE FAILURE; HUMAN; HYPOXEMIA; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; RESPIRATORY FAILURE; RESPIRATORY TRACT PARAMETERS; RETROSPECTIVE STUDY; THROMBOCYTE TRANSFUSION; TRACHEOSTOMY;

ARDS; EPOPROSTENOL; HYPOXEMIA; NITRIC OXIDE; PULMONARY VASODILATOR;

ADMINISTRATION, INHALATION; ANOXIA; ANTIHYPERTENSIVE AGENTS; APACHE; BRONCHODILATOR AGENTS; COMORBIDITY; CRITICAL ILLNESS; EPOPROSTENOL; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84883560293     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2013.03.006     Document Type: Article

References (16)

1. Walmrath D., Schneider T., Schermuly R., et al. Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome. Am J Respir Crit Care Med 1996, 153(3):991-996.
2. Rocca G.D., Coccia C., Pompei L., et al. Hemodynamic and oxygenation changes of combined therapy with inhaled nitric oxide and inhaled prostacyclin. J Cardiothorac Vasc Anesth 2001, 15(2):224-227.
3. Khan T.A., Schnickel G., Ross D., et al. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients. J Thorac Cardiovasc Surg 2009, 138(6):1417-1424.
4. Griffiths M.J.D., Evans T.W. Inhaled nitric oxide therapy in adults. N Engl J Med 2005, 353:2683-2695.
5. Buckley M.S., Feldman J.P. Inhaled epoprostenol for the treatment of pulmonary arterial hypertension in critically ill adults. Pharmacotherapy 2010, 30(7):728-740.
6. Rossaint R., Falke K.J., Lopez F., et al. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993, 328:399-405.
7. Zwissler B., Kemming G., Habler O., et al. Inhaled prostacyclin (PGI2) versus inhaled nitric oxide in adult respiratory distress syndrome. Am J Respir Crit Care Med 1996, 154(6 Pt 1):1671-1677.
8. Haraldsson A., Kieler-Jensen N., Nathorst-Westfelt U., et al. Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. Chest 1998, 114:780-786.
9. Van Heerden P.V., Blythe D., Webb S.A. Inhaled aerosolized prostacyclin and nitric oxide as selective pulmonary vasodilators in ARDS-a pilot study. Anaesth Intensive Care 1996, 24(5):564-568.
10. Petros A.J., Turner S.C., Nunn A.J. Cost implications of using inhaled nitric oxide compared with epoprostenol for pulmonary hypertension. J Pharm Technol 1995, 11(4):163-166.
11. Afshari A., Brok J., Moller A.M., et al. Inhaled nitric oxide for acute respiratory distress syndrome and acute lung injury in adults and children: a systematic review with meta-analysis and trial sequential analysis. Anesth Analg 2011, 112(6):1411-1421.
12. De Wet C.J., Affleck D.G., Jacobsohn E., et al. Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery. J Thorac Cardiovasc Surg 2004, 127(4):1058-1067.
13. Lowson S.M., Doctor A., Walsh B.K., et al. Inhaled prostacyclin for the treatment of pulmonary hypertension after cardiac surgery. Crit Care Med 2002, 30:2762-2764.
14. Fiser S.M., Cope J.T., Kron I.L., et al. Aerosolized prostacyclin (epoprostenol) as an alternative to inhaled nitric oxide for patients with reperfusion injury after lung transplantation. J Thorac Cardiovasc Surg 2001, 121:981-982.
15. Meyer J., Theilmeier G., Van Aken H., et al. Inhaled prostaglandin E1 for treatment of acute lung injury in severe multiple organ failure. Anesth Analg 1998, 86(4):753-758.
16. Camamo J.M., McCoy R.H., Erstad B.L. Retrospective evaluation of inhaled prostaglandins in patients with acute respiratory distress syndrome. Pharmacotherapy 2005, 25(2):184-190.